SCHEMBL7664066

SCHEMBL7664066

CCCc1cnc(-c2cccc(Oc3ccccc3)c2C(C)C)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L2 Q92843 2/20 0.37
▸ FYN P06241 2/20 0.35
▸ FEN1 P39748 5/20 0.33
▸ POLB P06746 2/20 0.33
▸ ALOX5AP P20292 3/20 0.32
▸ ATM Q13315 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ LTA4H P09960 1/20 0.32
▸ SREBF2 Q12772 1/20 0.32
▸ MAPT P10636 2/20 0.31
▸ HTT P42858 1/20 0.31
▸ CYP2D6 P10635 2/20 0.31
▸ SLC6A2 P23975 2/20 0.31
▸ SLC6A4 P31645 2/20 0.31
▸ SLC6A3 Q01959 2/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ HRH1 P35367 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ CCNT1 O60563 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666947 0.84 FEN1 (0.38) BCL2L2FYNFEN1POLBALOX5AP
SCHEMBL7664751 0.79 HTR2A (0.40) BCL2L2FEN1POLBALOX5APATM
SCHEMBL7664372 0.76 PLAU (0.41) L3MBTL1MAPTHTTNPSR1
SCHEMBL7666782 0.76 NPC1 (0.38) BCL2L2FYNFEN1POLBALOX5AP
SCHEMBL7670839 0.76 CYP11B1 (0.41) BCL2L2POLBATMLTA4HMAPT
SCHEMBL7666933 0.76 CYP11B1 (0.42) BCL2L2FEN1LTA4HSREBF2CYP2D6
SCHEMBL7672934 0.74 TTR (0.34) BCL2L2FYNFEN1POLBALOX5AP
SCHEMBL7664578 0.74 GRM5 (0.38) FEN1LTA4HMAPTBRD4
SCHEMBL7668578 0.72 L3MBTL1 (0.36) FEN1ALOX5APL3MBTL1SREBF2MAPT
SCHEMBL7673906 0.72 KEAP1 (0.39) L3MBTL1SREBF2MAPTHTTCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback